Glycogen synthase kinase-3 is an unusual protein serine/threonine kinase that, unlike most of its 500-odd relatives in the genome, is active under resting conditions and is inactivated upon cell stimulation. The two mammalian isoforms, GSK-3α and β, play largely overlapping roles and have been implicated in a variety of human pathologies, including Type II diabetes, Alzheimer's disease, bipolar disorder and cancer. Recently, the modes of regulation of this enzyme have been elucidated through a combination of structural and cell biological studies. A series of relatively selective small molecules have facilitated chemical manipulation of the enzyme in intact cells and tissues, and new roles for the protein kinase in embryonic stem cell differentiation and motility have emerged. Despite these advances, the therapeutic value of this enzyme as a drug target remains clouded by uncertainty over the potential of antagonists to promote tumorigenesis. This article describes the state of understanding of this intriguing enzyme, and weighs current evidence regarding whether there is a therapeutic window for amelioration of diseases in which it is implicated, in the absence of inducing new pathologies.
Skip Nav Destination
Article navigation
November 2004
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
October 26 2004
Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?
S. Patel;
S. Patel
1Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
Search for other works by this author on:
B. Doble;
B. Doble
1Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
Search for other works by this author on:
J.R. Woodgett
J.R. Woodgett
1
1Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
1To whom correspondence should be addressed (email jwoodget@oci.utoronto.ca).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
August 13 2004
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2004 The Biochemical Society
2004
Biochem Soc Trans (2004) 32 (5): 803–808.
Article history
Received:
August 13 2004
Citation
S. Patel, B. Doble, J.R. Woodgett; Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?. Biochem Soc Trans 1 November 2004; 32 (5): 803–808. doi: https://doi.org/10.1042/BST0320803
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.